DIAGNOS (CVE:ADK) Trading Down 2.8% – Time to Sell?

DIAGNOS Inc. (CVE:ADK)’s share price was down 2.8% during trading on Tuesday . The company traded as low as C$0.35 and last traded at C$0.35. Approximately 54,729 shares changed hands during trading, a decline of 40% from the average daily volume of 90,910 shares. The stock had previously closed at C$0.36.

Analyst Upgrades and Downgrades

Separately, Ventum Cap Mkts upgraded DIAGNOS to a “strong-buy” rating in a report on Wednesday, July 17th.

DIAGNOS Stock Down 2.8 %

The firm has a market capitalization of C$28.50 million, a PE ratio of -8.75 and a beta of -0.44. The company has a current ratio of 0.39, a quick ratio of 0.68 and a debt-to-equity ratio of 245.28. The firm has a 50-day moving average of C$0.35 and a two-hundred day moving average of C$0.32.

DIAGNOS (CVE:ADK) last released its quarterly earnings data on Wednesday, August 21st. The company reported C($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of C($0.02) by C$0.01. The business had revenue of C$0.04 million during the quarter, compared to analyst estimates of C$0.07 million. On average, equities research analysts forecast that DIAGNOS Inc. will post -0.02 EPS for the current year.

DIAGNOS Company Profile

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes.